Compare SWVL & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWVL | NVNO |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | United Arab Emirates | United States |
| Employees | 284 | 37 |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 7.2M |
| IPO Year | N/A | N/A |
| Metric | SWVL | NVNO |
|---|---|---|
| Price | $1.37 | $10.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.1K | 13.4K |
| Earning Date | 04-02-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $0.30 |
| 52 Week High | $4.99 | $12.85 |
| Indicator | SWVL | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 49.59 |
| Support Level | $1.34 | $9.76 |
| Resistance Level | $3.83 | $12.69 |
| Average True Range (ATR) | 0.07 | 1.05 |
| MACD | -0.00 | -0.23 |
| Stochastic Oscillator | 20.69 | 30.11 |
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.